Security Notice: Please be aware of impersonation attempts using our company name
Legitimate communications from Ascent Research will only come from official @ascentresearch.com email addresses.
Quick Order Cart

Cat. No. ARG39196

DNAJC13 Knockout A549 Polyclonal Cells

  • Product Type:

    Polyclonal Cell Population

  • Species:

    Homo sapiens (Human)

  • Tissue Source:

    Lung

  • Disease:

    Lung adenocarcinoma

CRISPR/Cas9-edited DNAJC13 polyclonal knockout A-549 cells offer a heterogeneous population for studying Hsp70 co-chaperone function in endosomal trafficking. Derived from human lung adenocarcinoma epithelial cells with a KRAS G12S mutation, this model is ideal for investigating retromer-mediated cargo sorting in a cancer context. DNAJC13 disruption impairs WLS/WNT signaling and autophagy, making the cells suitable for Parkinson??s disease research, WNT pathway analysis, and drug screening for retromer stabilizers. Key downstream targets include WLS and cathepsin D, with assays such as Western blotting and TOP/FOP Flash enabling detailed mechanistic studies.

Inquire Now

In stock

Ships next business day


Ask a Question

Shipping Info:

Cryopreserved in vials and shipped on dry ice


Disclaimer:

For Research Use Only

  • Characteristics

    Host Cell

    A549

    Sex of Donor

    Male

    Age

    58 years

    Derived From Site

    Lung

    Gene Name

    DNAJC13

    Gene Identifier

    NCBI Gene ID 23317

    Storage

    Liquid nitrogen (LN2)

  • Culture Conditions

    Growth medium

    MEM

    Supplement(s)

    10% Fetal Bovine Serum, 1% Penicillin-Streptomycin Solution

    Temperature

    37°C

    Atmosphere

    5% CO₂

  • Quality Control

    Sterility testing

    The bacterial, yeast, and fungi are not detected in these cells by daily monitor.

    Mycoplasma testing

    Negative for mycoplasma through PCR analysis

  • Disclaimer

    Intended Use

    This product is intended for laboratory in vitro use only. lt is not intended for diagnostic, therapeutic, or clinical applications.

    Disclaimer

    Ascent Research endeavors to provide accurate and up-to-date product information. However, no warranties or representations are made regarding its completeness or reliability. References to scientific literature and patents are for informational purposes only, and the customer assumes sole responsibility for verifying their accuracy.

    By accepting this product, the customer acknowledges and agrees to assume all risks associated with its receipt, handling, storage, disposal, and use, including compliance with all applicable safety and environmental regulations and precautions. Relevant laws, regulations, and ethical guidelines must be followed in conducting any research, modifications, or derivatives derived from this product.

    This product is provided "AS IS", and except as expressly stated herein, Ascent Research disclaims all other warranties, express or implied. Under no circumstances shall Ascent Research, its affiliates, or representatives be liable for indirect, incidental, consequential, or punitive damages arising from the use of this material. While Ascent Research employs rigorous quality control measures, we shall not be held responsible for damages resulting from misidentification or misinterpretation of the provided materials.

Description

This product consists of a CRISPR/Cas9-edited polyclonal knockout cell population in which the DNAJC13 gene has been disrupted in A-549 cells. The polyclonal pool provides a heterogeneous population of gene-edited cells, enabling loss-of-function studies without requiring single-cell cloning. The CRISPR/Cas9-mediated gene disruption ablates DNAJC13 expression, eliminating the Hsp70 co-chaperone function critical for endosomal trafficking. This knockout model serves as a robust tool for investigating retromer-dependent cargo sorting and associated cellular pathways.

The host cell line A-549, derived from a 58-year-old Caucasian male lung adenocarcinoma, displays adherent epithelial morphology and alveolar type II pneumocyte-like characteristics, including surfactant protein expression. It harbors a KRAS G12S mutation and wild-type p53, with KRAS-driven signaling that makes it a relevant model for non-small cell lung cancer. Its genetic and phenotypic profile provides a suitable cellular context for investigating endosomal trafficking.

DNAJC13 functions as an Hsp70 co-chaperone on endosomes, critically facilitating retromer-dependent cargo retrieval. It interacts with retromer core subunits VPS35, VPS29, VPS26 and sorting nexins SNX1/SNX2, as well as RME-8 and FAM21, to sort cargo such as WLS, sortilin, and cathepsin D from early endosomes to the TGN. This process is essential for WNT signaling, autophagic flux, and lysosomal enzyme delivery. Stress-induced transcription factors ATF6 and XBP1 upregulate DNAJC13 under unfolded protein response conditions. Gene disruption therefore impedes endosome-to-Golgi transport, attenuating WNT target gene activation and autophagy.

In A-549 cells, DNAJC13 knockout permits dissection of retromer function and WNT signaling within the KRAS-mutant lung cancer environment. Although DNAJC13 mutations are linked to Parkinson??s disease and neuronal ceroid lipofuscinosis, its fundamental role in membrane traffic is cell-type independent. This model allows exploration of how retromer-mediated sorting impacts autophagic degradation and WNT output in a cancer-relevant background, potentially identifying context-dependent dependencies for therapeutic intervention.

The knockout pool supports applications in Parkinson??s disease modeling, endocytic trafficking, WNT/autophagy research, and drug screening. Typical assays include Western blotting for retromer components, immunofluorescence co-localization, co-immunoprecipitation, RT-qPCR of WNT targets, WNT reporter assays, transferrin uptake, and LC3 turnover measurements. The model is valuable for evaluating retromer stabilizers and lysosomal protease activity in neurodegenerative disease studies. For additional information or custom inquiries, please contact Ascent Research.

Reset Password

    Reach Us Questions? Click Me Here!

    Fill out the form below and a member of our team will contact you shortly!

    *Required field



      Reach Us

      Fill out the form below and a member of our team will contact you shortly!

      *Required field

      Product Inquiry (Optional)